Pfizer Inc. recalls Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pf
Recalled May 25, 2022 · FDA recall D-0874-2022 · Pfizer
Hazard
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. · FDA Class II
Units
8346 bottles
Sold at
Nationwide and Puerto Rico
Description
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Product
Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →